BioNTech SE (BNTX) Non-Current Deffered Revenue (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Non-Current Deffered Revenue data on file, last reported at $878.7 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Deffered Revenue rose 178.85% year-over-year to $878.7 million; the trailing twelve-month figure through Dec 2025 stood at $878.7 million (up 178.85% YoY), and the FY2025 full-year result was $852.9 million, up 170.65% from the prior year.
• Non-Current Deffered Revenue eased to $878.7 million in Q4 2025, from $930.7 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $1.1 billion in Q2 2025 to a low of $48.9 million in Q1 2023.
• A 5-year average of $453.0 million and a median of $384.0 million in 2021 frame the typical range for Non-Current Deffered Revenue.
• Peak annual rise in Non-Current Deffered Revenue reached 768.29% in 2023, while the deepest fall reached 77.29% in 2023.
• Tracing BNTX's Non-Current Deffered Revenue over 5 years: stood at $212.9 million in 2021, then sank by 76.81% to $49.4 million in 2022, then jumped by 768.29% to $428.8 million in 2023, then retreated by 26.5% to $315.1 million in 2024, then jumped by 178.85% to $878.7 million in 2025.
• Business Quant data shows BNTX's Non-Current Deffered Revenue at $878.7 million in Q4 2025, $930.7 million in Q3 2025, and $1.1 billion in Q2 2025.